The Economist | Brexit and venture capital: Turning off the taphttps://t.co/s5d69nxjDK via @TheEconomist — The Propell Group (@ThePropellGroup) November 5, 2016 #healthtech
The Economist | Tracking down missing clinical trials: Tested, and found wantinghttps://t.co/TqGaqPibg0 via @TheEconomist — The Propell Group (@ThePropellGroup) November 5, 2016 #healthtech
Forbes Welcome https://t.co/qiOnPt1xGV — The Propell Group (@ThePropellGroup) November 4, 2016 #healthtech
Software Dreams Up New Molecules in Quest for Wonder Drugs https://t.co/YJMa7Fojn5 — The Propell Group (@ThePropellGroup) November 4, 2016 #healthtech
ASEAN alliance for angel investing launched with 7 countries https://t.co/e64WCIIdb1 — The Propell Group (@ThePropellGroup) November 4, 2016 #healthtech
Singapore likely to become a world leader in healthcare innovation https://t.co/OrZm4oR4PI — The Propell Group (@ThePropellGroup) November 4, 2016 #healthtech
Global Healthcare | 28 Deals, Investments & Transactions | Week 43 – Oct 2016 https://t.co/fwjsAiCKsP — The Propell Group (@ThePropellGroup) November 4, 2016 #healthtech
IoT Deceleration: Slumping Deal Activity To Internet Of Things Startups https://t.co/67f4LjHt1K — The Propell Group (@ThePropellGroup) November 3, 2016 #healthtech
By 2017, Gene Therapy Could Allow Us to Reverse Blindness https://t.co/YfDA2KRJo5 — The Propell Group (@ThePropellGroup) November 3, 2016 #healthtech
The Economist | Pharmaceuticals: Bad medicine https://t.co/Lq8whGsZbl — The Propell Group (@ThePropellGroup) November 3, 2016 #healthtech